Prescription Stimulant Misuse and ADHD Symptomatology Among College Students in Iceland
Tóm tắt
Objective: Misuse of prescription stimulant medication is a prevalent problem on American college campuses; however, few studies have been conducted beyond the United States. Although Iceland has the highest methylphenidate prescription rates in the world, prevalence of stimulant misuse within the Icelandic college student population remains to be investigated. Method: We examined the prevalence of prescription stimulant misuse among N = 521 college students in Iceland, using an online survey. Results: Overall prevalence of lifetime stimulant misuse was approximately 13%; 11% among participants without a prescription for stimulant medication, and 42% among participants holding a prescription. The primary reported reason for misuse was academic enhancement; risk factors included male sex, anxiety symptoms, and ADHD symptomatology. Conclusion: The present findings have implications for public health policy in Iceland, particularly as it relates to the college population. Prevention and intervention programs that provide college students with safer strategies to manage academic demands are warranted.
Từ khóa
Tài liệu tham khảo
American Psychiatric Association, 1994, Diagnostic and statistical manual of mental disorders, 4
Barkley R. A., 2008, ADHD in adults: What the science says
Eagan K., 2014, The American freshman: National norms fall 2014
Ingimarsson B. (2010). Próffræðilegt mat á DASS sjálfsmatskvarðanum: Þunglyndi, kvíði og streita [The psychometric properties of the DASS self-report scale: Depression, anxiety, and stress]. Unpublished manuscript, University of Iceland, Reykjavik, Iceland.
Lovibond S. H., 1995, Manual for the depression anxiety stress scales, 2
Munro B. A., Weyandt L. L., Marraccini M. E., Oster D. R. (2017). The relationship between nonmedical use of prescription stimulants, executive functioning and academic outcomes. Addictive Behaviors, 65, 250-257. doi:http://dx.doi.org/10.1016/j.addbeh.2016.08.023
National Institute for Health and Clinical Excellence. (2008). Diagnosis and management of ADHD in children, young people and adults (National Clinical Practice Guideline No. 72). London, UK. Retrieved from https://www.nice.org.uk/guidance/cg72/resources/attention-deficit-hyperactivity-disorder-diagnosis-and-management-975625063621
Pliszka S. R., 2014, Attention-deficit hyperactivity disorder, fourth edition: A handbook for diagnosis and treatment, 140
Reykjavik University. (2011). Nemendur í HR [Students at RU]. Retrieved from http://www.ru.is/haskolinn/tolfraedi/nemendur-i-hr/
Rottig D., 2009, International Business: Research, Teaching, and Practice, 3, 32
U.S. Food and Drug Administration. (2011). FDA drug safety communication: Safety review update of medications used to treat Attention-Deficit/Hyperactivity disorder (ADHD) in children and young adults. Retrieved from http://www.fda.gov/drugs/drugsafety/ucm277770.htm
University of Iceland. (2013). Heildarskráning nemenda í Háskóla Íslands frá upphafi [Total number of students enrolled at the University of Iceland since the beginning]. Retrieved from http://www.hi.is/adalvefur/heildarskraning_nemenda_i_haskola_islands_fra_upphafi_0